Repligen Corp
NASDAQ:RGEN
Repligen Corp
Cash from Operating Activities
Repligen Corp
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Repligen Corp
NASDAQ:RGEN
|
Cash from Operating Activities
$113.9m
|
CAGR 3-Years
22%
|
CAGR 5-Years
28%
|
CAGR 10-Years
16%
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Cash from Operating Activities
$8.4B
|
CAGR 3-Years
0%
|
CAGR 5-Years
13%
|
CAGR 10-Years
15%
|
|
Danaher Corp
NYSE:DHR
|
Cash from Operating Activities
$7B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
12%
|
CAGR 10-Years
7%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Cash from Operating Activities
$965.9m
|
CAGR 3-Years
10%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
Agilent Technologies Inc
NYSE:A
|
Cash from Operating Activities
$2B
|
CAGR 3-Years
17%
|
CAGR 5-Years
13%
|
CAGR 10-Years
6%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Cash from Operating Activities
$2.1B
|
CAGR 3-Years
3%
|
CAGR 5-Years
11%
|
CAGR 10-Years
19%
|
See Also
What is Repligen Corp's Cash from Operating Activities?
Cash from Operating Activities
113.9m
USD
Based on the financial report for Dec 31, 2023, Repligen Corp's Cash from Operating Activities amounts to 113.9m USD.
What is Repligen Corp's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
16%
Over the last year, the Cash from Operating Activities growth was -34%. The average annual Cash from Operating Activities growth rates for Repligen Corp have been 22% over the past three years , 28% over the past five years , and 16% over the past ten years .